These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3085299)

  • 21. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
    Rosenberg AS; Mizuochi T; Singer A
    J Exp Med; 1988 Jul; 168(1):33-45. PubMed ID: 2456372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis.
    Sugihara S; Izumi Y; Yoshioka T; Yagi H; Tsujimura T; Tarutani O; Kohno Y; Murakami S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Jul; 141(1):105-13. PubMed ID: 2967864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T; Shu S
    J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular subsets involved in cell-mediated immunity to murine Plasmodium yoelii 17X malaria.
    Mogil RJ; Patton CL; Green DR
    J Immunol; 1987 Mar; 138(6):1933-9. PubMed ID: 3102605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens.
    Hamilton BL
    J Immunol; 1987 Oct; 139(8):2511-5. PubMed ID: 3498761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunosuppressive effect of monoclonal anti-Lyt-1.1 antibodies in vivo.
    Michaelides M; Hogarth PM; McKenzie IF
    Eur J Immunol; 1981 Dec; 11(12):1005-12. PubMed ID: 6173235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection.
    Nakayama E; Uenaka A
    J Exp Med; 1985 Feb; 161(2):345-55. PubMed ID: 3871834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.
    Sprent J; Schaefer M; Gao EK; Korngold R
    J Exp Med; 1988 Feb; 167(2):556-69. PubMed ID: 2964497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cells mediating graft rejection in the mouse. II. The Ly phenotypes of cells producing tumor allograft rejection.
    Loveland BE; McKenzie IF
    Transplantation; 1982 Feb; 33(2):174-80. PubMed ID: 7036470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.
    Budd RC; Cerottini JC; Horvath C; Bron C; Pedrazzini T; Howe RC; MacDonald HR
    J Immunol; 1987 May; 138(10):3120-9. PubMed ID: 3106474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines.
    Kim B; Rosenstein M; Weiland D; Eberlein TJ; Rosenberg SA
    Transplantation; 1983 Nov; 36(5):525-32. PubMed ID: 6356516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
    Cobbold S; Martin G; Waldmann H
    Transplantation; 1986 Sep; 42(3):239-47. PubMed ID: 3529524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC.
    Rosenberg AS; Mizuochi T; Singer A
    Nature; 1986 Aug 28-Sep 3; 322(6082):829-31. PubMed ID: 3528862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-lymphocyte subsets: major histocompatibility antigens rejection of H-2K or H-2I region disparate skin allografts by either Lyt-2+ or L3T4+ T-lymphocyte subset.
    Smith DM; McKisic M; Stuart FP; Fitch FW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):162-4. PubMed ID: 2650100
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
    Nevala WK; Paul C; Wettstein PJ
    J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K; Jönsson JI; Falk I; Emmrich F
    Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression of graft rejection with idarubicin-monoclonal antibody conjugates by elimination of T cell subsets in vivo.
    Smyth MJ; Pietersz GA; McKenzie IF
    Transplantation; 1988 Jul; 46(1):126-31. PubMed ID: 2899362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for two distinct mechanisms in acute fatal graft-versus-host reaction across minor histocompatibility barriers.
    OKunewick JP; Buffo MJ; Kociban DL
    Exp Hematol; 1987 May; 15(4):365-72. PubMed ID: 3494625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and functional properties of murine thymocytes. I. Precursors of cytolytic T lymphocytes and interleukin 2-producing cells are all contained within a subpopulation of "mature" thymocytes as analyzed by monoclonal antibodies and flow microfluorometry.
    Ceredig R; Glasebrook AL; MacDonald HR
    J Exp Med; 1982 Feb; 155(2):358-79. PubMed ID: 6120202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
    Murphy WJ; Kumar V; Bennett M
    J Exp Med; 1987 Nov; 166(5):1499-509. PubMed ID: 3316472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.